Published in Health Insurance Law Weekly, December 25th, 2005
Validian's first solution, tailored for medical devices, pharmaceutical and biotechnology companies, secures the exchange of research and trial data.
By securing the electronic exchange of patient and product-performance data between physicians participating in research and trials and the research databases, the risk of theft, compromise or accidental loss of patient health information (PHI) is eliminated, the capture and collection of research and test...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.